2018
DOI: 10.1136/thoraxjnl-2018-211675
|View full text |Cite
|
Sign up to set email alerts
|

The effect of acute morphine on obstructive sleep apnoea: a randomised double-blind placebo-controlled crossover trial

Abstract: The Australian and New Zealand Clinical Trial Registry, ACTRN12613000858796.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

6
57
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 30 publications
(63 citation statements)
references
References 28 publications
6
57
0
Order By: Relevance
“…There was a 10% increase in percentage of sleep time spent below 95% oxygen saturation (T95%) with morphine intake ( p = .003), suggesting mild respiratory depression. In addition, there was a mild but statistically significant worsening in mean SpO 2 nadir (87.2 ± 5.7 vs. 86 ± 5.7%, p = .036) and mean PtcCO 2 (43.7 ± 4.1 vs. 45.9 ± 4.1 mmHg, p < .001) (Rowsell et al, ).…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…There was a 10% increase in percentage of sleep time spent below 95% oxygen saturation (T95%) with morphine intake ( p = .003), suggesting mild respiratory depression. In addition, there was a mild but statistically significant worsening in mean SpO 2 nadir (87.2 ± 5.7 vs. 86 ± 5.7%, p = .036) and mean PtcCO 2 (43.7 ± 4.1 vs. 45.9 ± 4.1 mmHg, p < .001) (Rowsell et al, ).…”
Section: Resultsmentioning
confidence: 99%
“…The sixty patients had an average age of 44.4 ( SD 11.7) years and BMI of 29.3 ( SD 3.9) kg/m 2 . Key PSG changes postmorphine have been described elsewhere (Rowsell et al, ). In general, 40 mg of controlled‐release morphine did not change key respiratory outcomes in AHI (placebo vs. morphine: 19.1 ± 17.7 vs. 20.7 ± 19.1/hr, p = .36), T90% (1.2 ± 3.1 vs. 1.6 ± 4.6%, p = .46) and ODI (14.3 ± 16 vs. 15.6 ± 15.6/hr, p = .36).…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations